112 related articles for article (PubMed ID: 9870639)
1. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1999 Mar; 119(2):281-4. PubMed ID: 10320092
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Olofsson J
Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
[TBL] [Abstract][Full Text] [Related]
4. In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Aarstad HH; Vintermyr OK; Ulvestad E; Kross K; Heimdal JH; Aarstad HJ
PLoS One; 2015; 10(6):e0129724. PubMed ID: 26079381
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulating effects of surgical intervention in tumors of the head and neck.
Dietz A; Heimlich F; Daniel V; Polarz H; Weidauer H; Maier H
Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):132-9. PubMed ID: 10889496
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
8. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
9. Suppressive factor or factors derived from head and neck squamous cell carcinoma induce apoptosis in activated lymphocytes.
Billings KR; Wang MB; Lichtenstein AK
Otolaryngol Head Neck Surg; 1997 Apr; 116(4):458-65. PubMed ID: 9141395
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results.
Liang F; Fan S; Han P; Cai Q; Lin P; Chen R; Yu S; Huang X
Surg Endosc; 2017 Feb; 31(2):894-900. PubMed ID: 27369288
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
13. E-rosette forming cells (E-RFC) in squamous cell carcinoma of the larynx and laryngopharynx.
Wig U; Saini AS; Gupta VK
J Laryngol Otol; 1983 Jun; 97(6):527-30. PubMed ID: 6602858
[TBL] [Abstract][Full Text] [Related]
14. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
[TBL] [Abstract][Full Text] [Related]
17. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
18. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinomas of the head and neck: descriptive analysis of 1293 cases.
Kurtulmaz SY; Erkal HS; Serin M; Elhan AH; Cakmak A
J Laryngol Otol; 1997 Jun; 111(6):531-5. PubMed ID: 9231086
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.
Corrigan CJ; Brown PH; Barnes NC; Tsai JJ; Frew AJ; Kay AB
Am Rev Respir Dis; 1991 Nov; 144(5):1026-32. PubMed ID: 1952427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
